Commit to R&D of innovative products to address unmet medical needs and to improve patients’ quality of life.
Pharmaceutical Products
Various products stemming from both internal R&D efforts and collaborations with partnerships
Research & Development
CLINCAL TRIALS
COVID-19 TESTING
PHARMACOVIGILANCE
MEDICAL FRONTIERS
Lee’s Pharmaceutical Holdings Limited is an investment holding company specialized in Development, Manufacturing, Sales & Marketing of internationally approved and qualified pharmaceutical products, which mainly focuses on China market. The company addresses a wide range of therapeutic areas, including: Cardiovascular health, Women’s health, Pediatrics, Rare diseases, Infectious diseases, Oncology, Dermatology, Obstetrics & Gynecology.
ผลิตภัณฑ์ที่พัฒนาขึ้นเองและผลิตภัณฑ์ยาสามัญ (Proprietary and Generic Products)
This segment includes development, manufacturing, and sale of self-developed and generic pharmaceutical products.
Key offerings include:
Nadroparin Calcium Injection and Fondaparinux Sodium Injection in remedy of blood clots and deep vein thrombosis.
Yallaferon to treat cervical erosion and viral infections.
Slounase for hemostasis.
Eyprotor is an impressive treatment for corneal ulcers.
Treprostinil Injection is a well-known remedy for pulmonary arterial hypertension.
Sodium Phenylbutyrate Granules are very effective in treatment of urea cycle disorders.